94 related articles for article (PubMed ID: 31465786)
41. NUP210 and MicroRNA-22 Modulate Fas to Elicit HeLa Cell Cycle Arrest.
Gu Q; Hou W; Liu H; Shi L; Zhu Z; Ye W; Ni X
Yonsei Med J; 2020 May; 61(5):371-381. PubMed ID: 32390360
[TBL] [Abstract][Full Text] [Related]
42. Alterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis.
Shishodia G; Shukla S; Srivastava Y; Masaldan S; Mehta S; Bhambhani S; Sharma S; Mehrotra R; Das BC; Bharti AC
Mol Cancer; 2015 Jun; 14():116. PubMed ID: 26051842
[TBL] [Abstract][Full Text] [Related]
43. Differential Expression Profiles of the Transcriptome in Breast Cancer Cell Lines Revealed by Next Generation Sequencing.
Shi Y; Ye P; Long X
Cell Physiol Biochem; 2017; 44(2):804-816. PubMed ID: 29176322
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-335 represents an independent prognostic marker in cervical cancer.
Wang C; Jiang T
Tumour Biol; 2015 Aug; 36(8):5825-30. PubMed ID: 25712373
[TBL] [Abstract][Full Text] [Related]
45. circMTO1 promotes tumorigenesis and chemoresistance of cervical cancer via regulating miR-6893.
Chen M; Ai G; Zhou J; Mao W; Li H; Guo J
Biomed Pharmacother; 2019 Sep; 117():109064. PubMed ID: 31226633
[TBL] [Abstract][Full Text] [Related]
46. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
47. Dysregulation of miRNA-21 and their potential as biomarkers for the diagnosis of cervical cancer.
Han Y; Xu GX; Lu H; Yu DH; Ren Y; Wang L; Huang XH; Hou WJ; Wei ZH; Chen YP; Cao YG; Zhang R
Int J Clin Exp Pathol; 2015; 8(6):7131-9. PubMed ID: 26261606
[TBL] [Abstract][Full Text] [Related]
48. Comprehensive transcriptomic analyses of tissue, serum, and serum exosomes from hepatocellular carcinoma patients.
Mjelle R; Dima SO; Bacalbasa N; Chawla K; Sorop A; Cucu D; Herlea V; Sætrom P; Popescu I
BMC Cancer; 2019 Oct; 19(1):1007. PubMed ID: 31660891
[TBL] [Abstract][Full Text] [Related]
49. Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma.
Wang J; Li Z; Ge Q; Wu W; Zhu Q; Luo J; Chen L
J Thorac Cardiovasc Surg; 2015 May; 149(5):1404-14.e4. PubMed ID: 25813410
[TBL] [Abstract][Full Text] [Related]
50. MiR-92a promotes tumorigenesis of colorectal cancer, a transcriptomic and functional based study.
Chen E; Li Q; Wang H; Yang F; Min L; Yang J
Biomed Pharmacother; 2018 Oct; 106():1370-1377. PubMed ID: 30119209
[TBL] [Abstract][Full Text] [Related]
51. Differentially Expressed miRNAs Influence Metabolic Processes in Pituitary Oncocytoma.
Krokker L; Nyírő G; Reiniger L; Darvasi O; Szücs N; Czirják S; Tóth M; Igaz P; Patócs A; Butz H
Neurochem Res; 2019 Oct; 44(10):2360-2371. PubMed ID: 30945144
[TBL] [Abstract][Full Text] [Related]
52. Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.
Xu Y; Zhao S; Cui M; Wang Q
Int J Clin Exp Pathol; 2015; 8(9):10294-304. PubMed ID: 26617737
[TBL] [Abstract][Full Text] [Related]
53. Regulatory network of circRNA-miRNA-mRNA contributes to the histological classification and disease progression in gastric cancer.
Cheng J; Zhuo H; Xu M; Wang L; Xu H; Peng J; Hou J; Lin L; Cai J
J Transl Med; 2018 Aug; 16(1):216. PubMed ID: 30068360
[TBL] [Abstract][Full Text] [Related]
54. MiR-195 Suppresses Cervical Cancer Migration and Invasion Through Targeting Smad3.
Zhou Q; Han LR; Zhou YX; Li Y
Int J Gynecol Cancer; 2016 Jun; 26(5):817-24. PubMed ID: 27206216
[TBL] [Abstract][Full Text] [Related]
55. MiR-362-3p is downregulated by promoter methylation and independently predicts shorter OS of cervical squamous cell carcinoma.
Song L; Liu S; Yao H; Zhang L; Li Y; Xu D; Li Q
Biomed Pharmacother; 2019 Jul; 115():108944. PubMed ID: 31082771
[TBL] [Abstract][Full Text] [Related]
56. Reduced expression of miR-503 is associated with poor prognosis in cervical cancer.
Yin ZL; Wang YL; Ge SF; Guo TT; Wang L; Zheng XM; Liu J
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4081-5. PubMed ID: 26592830
[TBL] [Abstract][Full Text] [Related]
57. Patterns of known and novel small RNAs in human cervical cancer.
Lui WO; Pourmand N; Patterson BK; Fire A
Cancer Res; 2007 Jul; 67(13):6031-43. PubMed ID: 17616659
[TBL] [Abstract][Full Text] [Related]
58. High olive oil diets enhance cervical tumour growth in mice: transcriptome analysis for potential candidate genes and pathways.
Zhang X; Yang P; Luo X; Su C; Chen Y; Zhao L; Wei L; Zeng H; Varghese Z; Moorhead JF; Ruan XZ; Chen Y
Lipids Health Dis; 2019 Mar; 18(1):76. PubMed ID: 30922331
[TBL] [Abstract][Full Text] [Related]
59. MiR-200b promotes the cell proliferation and metastasis of cervical cancer by inhibiting FOXG1.
Zeng F; Xue M; Xiao T; Li Y; Xiao S; Jiang B; Ren C
Biomed Pharmacother; 2016 Apr; 79():294-301. PubMed ID: 27044840
[TBL] [Abstract][Full Text] [Related]
60. Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.
Wu S; Gu Y; Huang Y; Wong TC; Ding H; Liu T; Zhang Y; Zhang X
Biochem Genet; 2017 Jun; 55(3):253-267. PubMed ID: 28315020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
